Akpay Sarybaev - Concepedia

Author

Akpay Sarybaev

National Center of Cardiology and Internal Medicine ORCID

Also Known As

A S Sarybaev, A Sh Sarybaev, A. S. Sarybaev, A. Sarybaev, A. Sh. Sarybaev, A.Sh. Sarybaev, A.Sh. Sarybaev Sarybaev, Akpai S Sarybaev, Akpai S. Sarybaev, Akpay S. Sarybaev

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

National Center of Cardiology and Internal Medicine Sechenov University Pirogov Russian National Research Medical University North-Western State Medical University named after I.I. Mechnikov Samara State Medical University

About

Akpay Sarybaev is an author at National Center of Cardiology and Internal Medicine specializing in medicine, public health, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	448
2	Public Health	10	10	325
3	Health Sciences	1	1	89
4	Biochemistry	1	1	21
5	Cell Biology	1	1	13

Akpay Sarybaev

Publications

914

Citations

H-Index

Page 1

	Year	Citations
Characterization of High-Altitude Pulmonary Hypertension in the Kyrgyz Almaz Aldashev, Akpay Sarybaev, Akylbek Sydykov, American Journal of Respiratory and Critical Care Medicine	2002	142
The Quality of Sleep and Periodic Breathing in Healthy Subjects at an Altitude of 3200 m J Zieliński, M Koziej, M Mańkowski, High Altitude Medicine & Biology Sleep DisordersSleep HealthHealthy SubjectsBreathing DisordersSleep-related Breathing Disorder	2000	89
EURASIAN CLINICAL GUIDELINES ON DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION I. E. Chazova, T. V. Martynyuk, А. S. Galyavich, Eurasian heart journal HypertensionPulmonary Arterial HypertensionCardiovascular DiseasePulmonary HypertensionPulmonary Medicine	2020	71
Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs Obolbek Turapov, B O'Connor, Asel A. Sarybaeva, Antimicrobial Agents and Chemotherapy	2016	52
Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, Russian Journal of Cardiology Russian FederationVirus EpidemiologyClinical SpecialtiesPopulation Health SciencesClinical Features	2021	51
Serial changes in nasal potential difference and lung electrical impedance tomography at high altitude Nicholas P. Mason, Merete Petersen, Christian Mélot, Journal of Applied Physiology	2003	49
SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension Christine Veith, Ipek Vartürk-Özcan, Magdalena Wujak, Circulation	2022	49
International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19 G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, Russian Journal of Cardiology Virus EpidemiologyCardiometabolic RiskViral DynamicShort-term Adverse OutcomesCovid-19 Epidemiology	2021	48
Hemoglobin Changes After Long-Term Intermittent Work at High Altitude Almaz Akunov, Akylbek Sydykov, Turgun Toktash, Frontiers in Physiology	2018	39
EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020) T. V. Martynyuk, Akchurin Rs, O. Ya. Vasiltseva, Eurasian heart journal HypertensionEvidence-based MedicineClinical SpecialtiesClinical GuidelinesPulmonary Hypertension	2021	34

Page 1